{"id":"W2061339803","doi":"10.1007/s10555-013-9433-9","title":"Targeting MAPK pathway in melanoma therapy","year":2013,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Vemurafenib; Melanoma; MAPK/ERK pathway; Medicine; Dabrafenib; Targeted therapy; Cancer research; Trametinib; Pharmacology; Drug resistance; Metastatic melanoma; Kinase; Cancer; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004460583,0.0009504022,0.001271509,0.00150282,0.0002453103,0.0007503079,0.0007603452,0.0009250856,0.002947177],"category_scores_gemma":[0.0004977216,0.0003086963,0.0004380585,0.001176715,0.0004101897,0.0009628852,0.0006451722,0.002530575,0.001712956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006112407,"about_ca_system_score_gemma":0.0007830163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001051977,"about_ca_topic_score_gemma":0.003320892,"domain_scores_codex":[0.9998837,0.0000169468,0.00001232514,0.00002037024,0.00004936865,0.0000173555],"domain_scores_gemma":[0.9998568,0.00005269784,0.00002099374,0.000004343879,0.00004271889,0.0000224212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001232724,0.0001190796,0.0001039806,0.007470129,0.00006557289,0.0001841837,0.000024676,0.0005093582,0.00413315,0.002586558,0.06726925,0.9174109],"study_design_scores_gemma":[0.00005658991,0.0001168076,0.0004921348,0.001423842,0.0001337195,0.0008166371,0.00002755057,0.0002866808,0.001066359,0.002006992,0.9935508,0.00002181523],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001128602,0.9979612,0.0002452189,0.000328533,0.0003672134,0.000006361889,0.00001715251,0.00001403265,0.0009474301],"genre_scores_gemma":[0.0008299344,0.9971445,0.0002946818,0.0003229577,0.0002898762,0.00001085609,0.00003356127,0.000002305899,0.00107135],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002947177,"threshold_uncertainty_score":0.009859324,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0835042255553753,"score_gpt":0.344842165141261,"score_spread":0.2613379395858857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}